|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103.9 USD | -1.22% |
|
-1.17% | +4.43% |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
| Apr. 15 | Market outlook is uncertain, but optimism prevails | |
May 13 (Reuters) - Moderna Inc said on Friday Swiss drugs regulator Swissmedic had authorized the use of its COVID-19 vaccine for children aged 6 to 11 years.
The approval is for the vaccine's two-dose series of 50 micro gram per dose, Moderna added. (Reporting by Shivani Tanna in Bengaluru; Editing by Rashmi Aich)
| 1st Jan change | Capi. | |
|---|---|---|
| +4.43% | 39.77B | |
| -0.10% | 42.07B | |
| +50.98% | 42.16B | |
| -11.36% | 26.68B | |
| +5.67% | 24.68B | |
| -22.84% | 18.68B | |
| -0.20% | 12.11B | |
| +26.30% | 11.99B | |
| +6.91% | 11.06B | |
| -15.09% | 10.3B |
MODERNA, INC. 
